Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from OMRON ( (JP:6645) ) is now available.
Omron reported consolidated net sales of ¥767.4 billion for the year ended March 31, 2026, up 7.3% year on year, with operating income rising 12.1% to ¥59.9 billion and net income attributable to shareholders jumping 75.1% to ¥28.5 billion. Profitability improved as the operating margin reached 7.8%, return on equity climbed to 3.5%, and comprehensive income surged, while the Devices & Module Solutions Business was reclassified as a discontinued operation.
The company strengthened its balance sheet as total assets expanded to ¥1.52 trillion and shareholders’ equity per share increased to ¥4,251.07, despite a slight decline in the equity ratio. Cash flows from operating activities improved to ¥60.9 billion, and Omron maintained an annual dividend of ¥104 per share with a lower payout ratio, while projecting higher full-year sales of ¥820 billion under IFRS from fiscal 2027 and planning a modest dividend increase to ¥110 per share, signaling confidence in earnings sustainability.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen6500.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
More about OMRON
Omron Corporation is a Japan-based industrial technology company listed on the Tokyo exchange, best known for factory automation systems, control equipment, and electronic components. It also operates businesses in social systems and healthcare, serving global manufacturing, infrastructure, and medical device markets with a focus on automation and sensing technologies.
Average Trading Volume: 1,555,837
Technical Sentiment Signal: Buy
Current Market Cap: Yen1199.5B
For a thorough assessment of 6645 stock, go to TipRanks’ Stock Analysis page.